Friday, 31 July 2015

Princess Health and 60% of the CEOs of America's "Great Health Systems" Have No Educational Background in Health Care. Princessiccia

Princess Health and 60% of the CEOs of America's "Great Health Systems" Have No Educational Background in Health Care. Princessiccia

We have noted that US health care has been taken over by generic managers.  A recent article about the CEOs of purportedly some of America's best hospitals provides some quantitative data.

A few days ago, Becker's Hospital Review published a list of the educational background of the CEOs of the "50 great health systems to know | 2015," (at least according to Becker's.  The article noted that their educational experiences took place at,

Ivy League schools, small liberal arts colleges, Big Ten universities, law schools, medical schools and more.

That is nice, but I decided to simply look at how many of the CEOs had educational backgrounds in medicine, other health care professions, public health, or the biomedical sciences.

Here is the breakdown of their most advanced degrees:

16 (32%) had medical doctorates
26 (52%) had a business administration degree, all but one at the master's level, and one a doctorate. 

The rest had various masters  and doctoral degrees in other fields. 

Note that two of the MDs also had MBAs, and one had a JD (law degree).

The business administration degrees included MBAs, but also degrees in health, hospital administration.  Of those with these degrees, one also had a bachelors degree in pharmacy, and one in biology.

One CEO was listed as attending a nursing school, but no degree or certificate from that experience was listed.

Comment

In any case, the majority, more than 60% of the CEOs of some of America's most prestigious hospitals (by at least one measure) clearly had no educational background in medicine, another health profession, public health, or biomedical science.  Again, this demonstrates that the top leaders of the top US health care organizations are more often management, rather than medicine, health professional.

This is corroborated by other observations.  In 1988, Alain Enthoven advocated in Theory and Practice of Managed Competition in Health Care Finance, a book published in the Netherlands, that to decrease health care costs it would be necessary to break up the "physicians' guild" and replace leadership by clinicians with leadership by managers (see 2006 post here). Thus from 1983 to 2000, the number of managers working in the US health care system grew 726%, while the number of physicians grew 39%, so the manager/physician ratio went from roughly one to six to one to one (see 2005 post here). As we noted here, the growth continued, so there are now 10 managers for every US physician.

Why is this a problem?   The managers who first took over health care may have had some health care background.  Now it seems that health care managers are decreasingly likely to have any health care background, and increasingly likely to be from the world of business.  Meanwhile, for a long time, business schools seem to have been teaching managers that they have a God given right to manage every organization and every aspect of society, regardless how little they know about what the particular context, business, calling, etc involves.  Presumably this is based on a faith or ideology that modern management tools are universally applicable and nigh onto supernatural in their powers.  Of course, there is not much evidence to support this, especially in health care.

We have discussed examples of bizarre proclamations by generic managers that seem to corroborate their belief in such divine powers.  Most recently, there was the multimillionaire hospital system CEO (who is on the list, and whose highest non-honorary degree is a masters in philosophy and political science) who proclaimed new artificial intelligence technology could replace doctors in short order (look here).    We have noted many cases of management of health care organizations that was ill-informed, and indifferent or even hostile to the core values of health professionals

I believe true health care reform would enable health care leadership by people who understand the actual care of patients, uphold health care professionals' values, and are willing to be accountable for putting patients' and the public's health first. 

But this sort of reform would challenge the interests of managers who are getting very rich off the current system.  (See some examples of grandiose executive compensation in health care here.)  So I expect lots of resistance to any proposals to push health care leaders to be more knowledgeable about health care and sympathetic to its values. 

Thursday, 30 July 2015

Princess Health and Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year. Princessiccia

Princess Health and Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year. Princessiccia

The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an elevated price.  Like other drugs recently introduced as blockbusters, the high price does not seem clearly justified by clinical evidence about the drug's benefits and harms.  


Questions Raised by the One Big Published Controlled Trial

Last year, we discussed the hoopla around a study of a new drug for congestive heart failure (CHF),(1) a fixed combination of valsartan and sacubitril. Also, on the now defunct CardioExchange blog, Dr Vinay Prasad discussed the same study (look here, and scroll down.) We both concluded that the (apparently multiply flawed) design of the study left important questions unanswered.

Does Sacubitril Actually Work?

 The PARADIGM-HF study compared patients given valsartan plus sacubitril to patients given enalapril.  Valsartan, an angiotensin receptor blocker (ARB) and enalapril, an angiotensin converting enzyme inhibitor (ACEI) have both been shown separately to improve symptoms and function, decrease morbid events, and extend life for patients with systolic CHF.  However, the PARADIGM-HF study compared a high dose of valsartan, 160 mg twice a day, (plus sacubitril) to a medium dose of enalapril, 10 mg twice a day.  Apparently, no trial comparing just valsartan 160 mg to enalapril 10 mg twice a day has been done.  So it is quite possible that a high dose of valsartan is better than a medium dose of enalapril.  Thus, PARADIGM-HF could not prove that sacubitril has any benefit independent of high dose valsartan.

What are the Adverse Effects of Sacubitril (With or Without Valsartan) Likely to be in Practice?

The PARADIGM-HF design prevented any assessment of the adverse effects of sacubitril independent of those of valsartan.  Furthermore, the trial had an active run-in period which resulted in the exclusion of  patients who failed to tolerate valsartan-sacubitril in a pre-trial run-in period.  This effectively biased downward the prevalence of adverse effects due to the combination reported during the trial.  Finally, the trial, while big, was not big enough to discover rare but severe adverse effects.  Thus, one cannot easily tell how the benefits of valsartan-sacubitril compare to its harms, or how the benefits of sacubitril alone compare to its harms.

How Would Valartan-Sacubitril Work for Patients with Common Diseases in Addition to CHF?

The study excluded patients with common conditions that may afflict CHF patients, including relatively severe coronary artery disease, severe lung disease, ulcers and liver disease.  CHF patients are often elderly and often have other diseases, but how the drug might work for them is unclear.

Other Doubts and Questions

In a recent Medscape post, Dr John Mandrola noted additional problems with the study that raise doubts about its validity.  These included its early termination, the very large number (1000) of study sites raising doubts about quality control of implementation and data collection, and the finding, not emphasized by the authors, that valsartan-sacubril caused an apparent increase in hypotension, a significant issue for CHF patients.

As far as I can tell, there have been no other big trials of sacubitril, with or without valsartan, so there are no other source of clinical research data to address these questions.  As we noted here, one of the most prominent PARADIGM-HF investigators tried to rebut Dr Prasad, but did so mainly by employing logical fallacies.

So in my humble opinion, there is only weak, ambiguous data to show valsartan-sacubitril produces benefits that outweigh its harms for congestive heart failure patients seen in usual clinical practice.

More Enthusiasm and Hype about Entresto

These questions about the one big study of valsartan-sacubitril did not deter the US Food and Drug Administration (FDA) from approving it.  As soon as it was approved, the hype machine started up in a big way.

Per the NY Times,

'This is one of those once-in-a-decade kind of breakthroughs, to get a drug that extends life so substantially,' David Epstein, the head of Novartis�s pharmaceutical division, said in an interview.

Per the Wall Street Journal,

Clyde Yancy, chief of cardiology at Chicago�s Northwestern Memorial Hospital, said that Entresto is 'one of the few times that we have identified a medication that is better than the standard. It�s clearly superior to what we have.'

Per a Medscape news post, Dr Clyde Yancy also said,

A year later, I continue to feel that this is, in fact, a reflection of a new day�for patients and for the opportunity to reenergize the community. It's also a huge endorsement for the importance of science in cardiovascular medicine.

And Dr Milton Packer (who had countered Dr Pradad's critique of PARADIGM-HF with logical fallacies, said,

I think they considered the data to be compelling and strong. And I think that when physicians look at the data, they will be convinced that this drug will become a cornerstone of treatment for heart failure.

The Medscape article did document some doubts.  Dr John G Cleland of Imperial College, London, UK allowed that the active run-in group was among "issues that have yet to be settled," Dr Marriell Jessup who had written a positive editorial in the NEJM when the trial was published(2) allowed that the lack of patients with co-morbities might be a problem.  Finally, Dr Yancy allowed that the early termination might be a problem.   Yet each focused on a single problem with the study, and none of these physicians seemed to acknowledge the totality of the study's problem.  Neither did any of them seemed to let these doubts dampen the enthusiasm, e.g., at the end of the article, quoting Dr Yancy,

Can we change the narrative?  I believe it's time to take the 'failure' out of heart failure and look at what we can do to generate success.
Note that the article disclosed Dr Cleland does research funded by Novartis, maker of Entresto, and Dr Packer is a consultant to Novartis.  Is is possible these commercial relationships tempered any concerns that might have had about the study design. 

I realize that CHF is a miserable problem for patients, and clearly leads to severe symptoms, multiple hospitalization, and sometimes early death.  So I understand why people may be enthusiastic about a new therapy for it, especially if their research or consulting is funded by the drug's manufacturer.  But is it crystal clear the latest innovation is that good?

Billions of Dollars in Play

But never mind those unanswered questions and the multiple problems with the PARADIGM-HF trial, Entresto, the trade name for valsartan-sacubitril will not be cheap.  Per the NY Times,

Novartis said Entresto would cost about $12.50 a day, or about $4,500 for a year....

Novartis wants to convince you that it's not really that expensive

Mr Epstein said the price was 'really quite reasonable,' given that some drugs for other diseases cost many times that amount and confer less benefit.

He is certainly right that some drugs are even more expensive. However, is argument is just an appeal to common practice.  Whether the prices of other drugs are justified by strong evidence about their benefits and harms may not be clear. The benefits conferred by Entresto, and the harms it may cause as we belabored above, are really not that certain either. 

In the financial news, you could almost imagine the salivation.  Per the WSJ,

Wall Street predicts Entresto will be a blockbuster, with Leerink Partners estimating that annual global sales could top $6 billion by 2024.

In Reuters,

Expectations for Entresto have been building since it won early U.S. approval and Novartis set a higher than expected price, with analysts now forecasting $4.7 billion of sales in 2020, according to Thomson Reuters Cortellis.

Chief Executive Joe Jimenez said Entresto sales would take time to ramp up but growth would accelerate in 2016. Reception to the new drug, which Novartis started shipping within 24 hours of U.S. approval this month, has been good and there was little resistance to the $12.50 daily cost.

'The average hospital stay for a heart failure patient in the United States is $11,000,' Jimenez told reporters. 'So we are not receiving pushback on the price because I think this is seen as good value.'

Compared to what? Again, it is not clear that Entresto would be better than generic enalapril dosed at 20 mg/day, which is a lot cheaper than $4,500 a year.  But could it be that visions of billions of dollars have clouded some peoples' thinking, at least people paid by or owning stock in Novartis?

Summary

We have posted frequently about the blockbuster drug Sovaldi promoted as a cure for deadly hepatitis C infections.  Yet while the evidence that Sovaldi and its competitors are really so good, really provide cures, and really will prevent many patients from dire consequences of hepatitis C is not so strong, the US price of these drugs is stratospheric.

Now we have Entresto, whose price is not so stratospheric, but still quite high, and whose benefits compared to its harms are not clearly supported by evidence from clinical research.

 Unfortunately, Entresto (valsartan-sacubitril) is now one of a long line of new drugs that are breathlessly hyped, often by people who should know better, despite weak evidence in their favor.  It is one of a long list of examples of drugs approved based on poorly designed studies whose design flaws seem likely to make their commercial sponsors' products look better.  As a recent post in Health Affairs by Christopher Robertson reminds us, while many industry supporter act like allowing drug and device manufacturers to support (and usually control) most of the clinical research meant to evaluate their own products in inevitable,

When one steps back from our current practices, it should appear rather odd that we rely on companies to test the safety and efficacy of their own products. It would be as if a litigant were allowed to choose and fund its own judge, or an athlete to hire her own referee.

To convince us that we live in the best of all possible worlds, however, the media is full of proclamations that we are in a new era of marvelous medical and health care "innovations" that will bring us all untold benefits.  The notion that physician-industry collaboration is necessary to continue to produce these wondrous "innovations" is a talking point used to counter those who criticize conflicts of interest affecting academic medicine (look here).   Yet the evidence supporting many game-changers and blockbusters is often weak and ambiguous.  This rarely seems to deter the drug, device and biotechnology industry from charging more and more for them.


The sober, evidence-based medicine approach is being lost in all the hoopla and hucksterism.  We are adopting treatments of unproven value, whose benefits may be much less, and harms may be much worse than we imagine, and paying unconscionsable prices for them.  The results for patients and society include our ever rising health care costs, ever challenged access, and no evidence that outcomes are better for patients.

True health care reform would encourage sober discussion of the evidence, of benefits and harms, and of fair pricing, and would challenge the hype, hucksterism, and conflicts of interest that all swirl around modern health care. 



References

1.   McMurray JJV, Packer M, Desai AS et al.  Angiotensin - neprilysin inhibition versus enalapril in heart failure.  N Engl J Med 2014; DOI: 10.1056/NEJMoa1409077  Link here.

2.  Jessup M. Neprilysin inhibition - a novel therapy for heart failure.  N Engl J Med 2014;  DOI: 10.1056/NEJMe1409898.  Link here.

Wednesday, 29 July 2015

Princess Health and 2015 #SummerTT. Princessiccia

With approximately 100 participants, the 2015 #SummerTT was our largest, most competitive, and most fun TT yet.

Since the course length is an odd 2.2K along with being extremely challenging (rolling hills, gravel, uneven terrain, and tight corners), this race has become notorious for being extremely painful, somewhat random, yet impossible to resist!  Anybody who has ever trained in Waterloo within their life has likely done some sort of session at Waterloo Park.  Because of this course experience, we have a home court advantage stemming from our intimate knowledge of this 1.1K loop.  The #SummerTT allows us to put this experience to use, showcase our speed, and run the Waterloo Park ring road better than anybody else can.  Here is a little taste of how this year's edition went:

Course Records 
(updated as of July 27th, 2015)

Overall Men: 6:13 Adam Hortian (July 27th, 2015)
Overall Women: 7:06 Vicky Siemon (July 28th, 2014)

Masters Men: 7:03 Larry Bradley (July 27th, 2015)
Masters Women: 8:40 Val Hobson (July 27th, 2015)

Junior Men: 7:19 Aidan Rutherford (July 27th, 2015)
Junior Women: 9:34 Nicole Shrigley (July 28th, 2014)

50+ Men: 7:25 Dave Rutherford (July 28th, 2014)
50+ Women: 10:42 Heidi Engelhardt (July 27th, 2015)

60+ Men: 8:26 Dean Foster (July 27th, 2015)
60+ Women: 11:31 Gail Delanghe (July 30th, 2012)

Full Results

H+P Kid's Dash


The first year of the H+P Kid's dash was awesome!  We had around 20 kids aged 0-9 tackle the 300m course, finishing to a cheering crowd of friends and family.  Familiar faces to H+P practices Jake Howard and Jenna Martin won the race for boys and girls respectively.




Results Summary

The 2015 #SummerTT was packed with a number of record breaking performances.  Here they are:

-Adam Hortian, who won the race OA, averaged 2:50/K to lower the new course record to 6:13.
-Larry Bradley, a specialist in duathlons, had a huge performance to break the Masters course record, setting the new bar at 7:03.
-Aidan Rutherford became the second Rutherford on our records list, setting a new junior record of 7:19 (and beating his dad in the process!)
- Tracy Urquhart took down one of our longest standing records- Masters women- with a time of 9:19.  In the next wave, Val Hobson bettered that record, running 8:40, taking over a minute off the previous best.
- With another one of our longest standing records- 60+ Men- Dean Foster put in a very strong effort to take over 2 minutes off our previous record, running 8:26.
For women 50+, Heidi Engelhardt ran a very strong record performance of 10:42!

Other notable performances include:
- Vicky Siemon was able to repeat her OA win and defend her title
- Dave Rutherford repeated as the 50+ champ
- Nicole Shrigley was the fastest junior girl for the 4th year in a row

Volunteers and Donations
This event simply would not have been possible without the help of our volunteers and those who donated to the event.

Music from Don't Tell My Mother 

Sponsors

Finally, we have to thank our outstanding sponsors for all their contributions in making this event great!






New Balance Canada


RoadID


Mike Hewitson
Sales Representative with ROYAL LePAGE



Runner's Choice Waterloo



Delanghe ChiropracticFD


The next #SummerTT is only 1 year away!  Monday July 25th, 2016- mark it on your calendars.  Follow the event website HERE for updates as they come.






#cantwontstop

Princess Health and Thank you #SummerTT volunteers! .Princessiccia

The #SummerTT simply would not have been possible without our volunteers.  Thank you everybody on this list who helped to make the even such a success, and fun for all!



  • Craig Kingston- course set up, registration, jack of all trades!
  • Helen Broom- course set up
  • Payton Thiel- lots of stuff! 
  • Brendan Hancock- traffic control, starter
  • Neil Malhotra- traffic control
  • Matt Chandler- traffic control
  • Alex Zorzitto- traffic control
  • Emily Hunter- lots of stuff!
  • Mike Bitton- lead cyclist 
  • Will Spaetzel- video man!
  • Jonathan Fugelsang- photographer
  • Dawn Frier- photographer
  • Cari Rastas Howard- lots of stuff!
  • Adam Dixon- traffic control
  • Lloyd Schmidt- race set up
  • Dave Korell- race set up, try-on event, awards
  • Stefano Boccia- race set up, dressing up as Newbie
  • Laura and Mike Hewitson- going way above as beyond running the food tent!
  • Don't Tell My Mother- crushing the acoustic set


If we missed you on this list, please let us know!!  Thank you all!

Sunday, 26 July 2015

Princess Health and SummerTT #'s.Princessiccia

Princess Health and SummerTT #'s.Princessiccia


Bib Number First Name Last Name
201 Dave Rutherford
202 Ahmed Ahmed
203 Robert Brouillette
204 Nick Burt
205 Lucas Shwed
206 Adam Hortian
207 Michael Piazza
208 Chris Goldsworthy
209 Kailey Haddock
210 Valery Hobson
211 Tyler Fronchak
212 Aidan Rutherford
213 Greg Dyce
214 Matt Chandler
215 Aaron Mailman
216 David Haiser
217 Jonathan  Gascho
218 Larry Bradley
219 Jeff Martin
220 Robyn Collins
221 Vicki Zandbergen
222 Helen Stubbs
223 Jonathan Fugelsang
224 Emily Hunter
225 Derek Hergott
226 Kristin Marks
227 Manny Jones
228 Kimberley Chan Ah Song
229 Harold OKrafka
230 Sam Lalonde
231 Aditya Patil
232 David Layden
234 Ed Shrigley
233 Candy Shrigley
235 Linda Farczadi
236 Schuyler Schmidt
237 Steven Parke
238 Don Macleod
239 Paul Gonsalves
240 Maddie Hobson
241 Samantha Wiebe
242 Nicole Shrigley
243 Jae Lee
244 Kevin Wolfe
245 Adam Dixon
246 Dean Foster
247 Leroy Chen
248 Kyle MacKenzie
249 Matthew Chan
250 Shawn Wilson
251 Andre Chan
252 Nick Van Moorsel
253 Martin Chmiel
254 Erik Vicujnik
255 Eric Lucko
256 Tracy Urquhart
257 Heidi Engelhardt
258 Tammy Hergott
259 Samara Hergott
260 Olivia Hergott
261 Jennifer Merrett
262 Cari Rastas Howard
263 Tracey Kuchma
264 Natasha Guz
265 Aibhlin Kennedy
266 Beverly-Anne Ward
267 Nicholas Hobson
268 Charlotte Vasarhelyi
269 Christopher Phillips
270 Debbie Iwanyzki
271 Emily Willard
Princess Health and What They Really Think of Us, UK Version - Health Secretary Derides NHS Doctors for Not Working Enough on Weekends. Princessiccia

Princess Health and What They Really Think of Us, UK Version - Health Secretary Derides NHS Doctors for Not Working Enough on Weekends. Princessiccia

A new story from the UK suggests what top leaders of health care really think about health care professionals.  I realize that I risk showing my shallow understanding of UK politics when I comment on this, but I believe that the story is straightforward enough for someone from the US to understand, and has  lessons for the US and other countries.

UK Health Secretary Says Doctors Do Not Work Enough on Weekends

The story started earlier in July, 2016, when the current UK Health Secretary within the current Conservative government told National Health System (NHS) doctors they must work seven days a week, as reported by the Guardian,


The health secretary, Jeremy Hunt, has accused the main doctors� union of walking out of NHS consultants� [equivalent to US attending physicians] contract talks aimed at preventing 'catastrophic consequences' for patients at weekends.

Hunt said he recognised the efforts of consultants, many of whom already work on Saturdays and Sundays, but that he would impose weekend-working contracts by September if an agreement could be reached.

Also, 


The proposed contract would have at its core the controversial weekend working provision, but would include the abolition of overtime payments that Hunt has described as extortionate.

 Under the current contract, last negotiated by Labour in 2003, consultants can opt out of non-emergency work outside the hours of 7am to 7pm Monday to Friday.

Mr Hunt implied that insufficient physician presence on weekends was leading to catastrophe.

Hunt will say: 'Around 6,000 people lose their lives every year because we do not have a proper seven-day service in hospitals. No one could possibly say that this was a system built around the needs of patients and yet when I pointed this out to the BMA they told me to �get real.� I simply say to the doctors� union that I can give them 6,000 reasons why they, not I, need to �get real�.'

However, UK Doctors, Including Consultants, Do a Lot of Work on Weekends

Within a few days, there was an amazing response from UK physicians showing that what the Health Secretary seemed to believe about how NHS hospitals work was, not to put too fine a point on it, wrong.

From the Guardian came a piece by an anonymous trainee physician,

Last weekend, for the first time ever, I managed to make something trend on Twitter. It wasn�t a witty comment about Andy Murray triumphing in the Davis Cup, nor was it a retweet of a picture of somebody else�s cat.

I simply told a man called Jeremy that I was at work that night.

Three days later, thousands of people were telling Jeremy that they too were at work that weekend, using the hashtag #iminworkjeremy. Day and night, Friday to Monday, a large group of people felt Jeremy simply had to know what they were up to.

Because Jeremy is fairly important in the running of the country. Well, part of the country anyway � that part where the sick can just turn up and be treated without money changing hands. The part I work in, in fact, as a junior doctor.

Jeremy is concerned about how his part of the country is being run. He is upset that the ones who keep the sick alive � the doctors � aren�t there at weekends.

It�s just a pity Jeremy is wrong.

The Jeremy in question is, of course, secretary of state for health, the Rt Hon Jeremy Hunt, who last week announced he would bring in a 24-hour health service, seven days a week. To do this, he would alter consultant contracts to stop them including an 'opt-out' from weekend working � by force, if need be. To bolster his point, he told the public that there were not many consultants in at the weekends, and also that you were more likely to die if you came to hospital at a weekend.

I am not a consultant, far from it, but I do know that if and when I become a consultant, I will work weekends and I will be in at night. I accepted this when I took the role on.

So why did I, and the rest of my campaign group, tell the nation�s health workers to tell Mr Hunt that we were indeed working over the weekend?

I think, firstly, it was in answer to the claim that consultants do not work on Saturdays and Sundays. Our campaign has demonstrated that, day and night, there are doctors of all grades at work, often working unsociable hours.

The article also pointed out that having a consultant (the equivalent in the US of attending physician) available on the weekends may not lead to true seven day service if what the consultant orders is not available on weekends.

Two days later, another junior doctor's response to Mr Hunt had gone viral, as reported by the Mirror,

In an open letter, paediatric junior doctor Benjamin Carter, said health professionals felt 'upset, demoralised and feeling entirely unappreciated' after Mr Hunt painted them as 'lazy, money-grabbing, unprofessionals' who were opposed to 24-7 healthcare.

Also,


He said: 'Please allow me to paint a picture for you, as I am sure you are aware by now due to the #?IminworkJeremy movement, a great many doctors work weekends. I for one tend to work 1 in every 3.

'This includes juniors and consultants, my consultants in particular have a rota for who is covering the weekends day and night because we need that expertise. When on call for that weekend, my consultants do ward rounds, they see sick children, they are present for the emergencies that their wealth of experience and knowledge helps resolve.

'They do not opt out, they do not complain, and they certainly do not go straight back to the golf course. They might not always be on site for the whole 72 hour weekend, but they are never more than a phonecall away.

'I look up to my consultants as pillars of excellence and professionalism. For you to say that we as a group operate with a lack of vocation and professionalism is not only false, it is gravely insulting.'

Dr Carter posted his letter to Facebook, where it has been shared more than 5,000 times in just a few hours.

In addition,

In a moving section, he explained that much of the anger aimed among doctors is because they have to deal with life and death on a daily basis, for a relatively modest wage.

He said: 'Already our pay is comparable to a high street manager [equivalent to a manager of a shop on Main St in the US], and that it pails in comparison to a city [equivalent in the US to Wall Street] worker and that neither of those professions require their workers to deal with life and death daily, to endure aggression from those we are trying to help and to be reduced to tears that result from exhaustion and the sheer emotional burden of our daily work.

'I invite you to come to my place of work and be there holding a dying child's hand and then tell me afterwards that I don't have a sense of vocation.'

A day later, a UK consultant calculated just how "extortionate" his overtime payments were, per the Independent,

A consultant angered by Health Secretary Jeremy Hunt's claims that a 'Monday to Friday' culture exists within the NHS has published an honest account of exactly how much he earns on call and at weekends.

Karan Kapoor posted the no holds barred letter to his Facebook page, describing what he takes home as a newly-appointed NHS ENT (Ear, Nose and Throat) consultant when working outside his usual hours.

His on-call supplement per month, he reveals, pays just �313.54 [currently = $532.49] - the equivalent of �2.61 [currently = $4.05] per hour and significantly less than the minimum wage. 

He concluded,

'I am genuinely offended that you have openly questioned my professionalism and vocation or that of my colleagues,' Mr Kapoor writes.

'I am no different to the thousands of Consultants, Junior Doctors, Nurses, Physios, Pharmacists, Secretaries, Speech Therapists, etc.

'We don't go on strike, we don't hold the country to ransom, we don't compromise patient care because we were meant to go home 2 hours ago, instead we go above and beyond, understanding the true meaning of professionalism and being exemplar to any health service in the world.

'Without this silent and diligent commitment, the NHS would have crumbled many years ago.'

The story also noted the groundswell of anger inspired by Mr Hunt's implication that today's NHS doctors do not work on weekends,

Last week a petition to call a debate on a vote of no confidence in the Health Secretary hit 100,000 - the required number of signatures to be considered for debate in Parliament - in less than 24 hours.

The petition, which was started by Dr Ash Sadighi, argues that Mr Hunt has 'alienated the entire workforce of the NHS' with his plans 'to impose a harsh contract and conditions on first consultants and soon the rest of the NHS staff.'

Finally, the Independent documented another online outburst generated by a consultant surgeon posting a picture of "himself moping a hospital floor" on Facebook.

What Generic Managers Really Think of Health Professionals

We have frequently discussed how US health care has been taken over by generic managers.  In 1988, Alain Enthoven advocated in Theory and Practice of Managed Competition in Health Care Finance, a book published in the Netherlands, that to decrease health care costs it would be necessary to break up the "physicians' guild" and replace leadership by clinicians with leadership by managers (see 2006 post here). Thus from 1983 to 2000, the number of managers working in the US health care system grew 726%, while the number of physicians grew 39%, so the manager/physician ratio went from roughly one to six to one to one (see 2005 post here). As we noted here, the growth continued, so there are now 10 managers for every US physician.

The managers who first took over health care may have had some health care background.  Now it seems that health care managers are decreasingly likely to have any health care background, and increasingly likely to be from the world of finance.  Meanwhile, for a long time, business schools seem to have been teaching managers that they have a God given right to manage every organization and every aspect of society, regardless how little they know about what the particular context, business, calling, etc involves.  Presumably this is based on a faith or ideology that modern management tools are universally applicable and nigh onto supernatural in their powers.  Of course, there is not much evidence to support this, especially in health care.

I have every reason to believe the idea that "professional" managers and business people should be in charge of all parts of society and all economic sectors has spread well outside the US.  UK Health Secretary Jeremy Hunt seems to be an example.  His background, according to the Gov.UK website, is that "Before his election as an MP, Jeremy ran his own educational publishing business, Hotcourses."  A Financial Times article noted that in 2014, he still had a major financial interest in the company,

Jeremy Hunt, the health secretary, has suffered a setback in his attempt to sell his education listings business after private equity group Inflexion pulled out of a proposed �35m deal.

Hotcourses, which claims to be the world�s largest database of educational courses, was set up by Mr Hunt and his business partner, Mike Elms, in 1996, before he entered parliament.

The article noted further, ironically in regard to the Mr Hunt's recent controversy,

The deal was an awkward reminder for the coalition of the large personal wealth of many cabinet ministers at a time when Labour has criticised the government for being 'out of touch' with ordinary voters.

As far as I could tell, before his political  career, Mr Hunt was a businessman with no experience or expertise in health care or biomedical science. And as of May, 2015, according to the the ThisIsMoney.uk website, Actually, he still seemed to be a businessman.  Mr Hunt still owned nearly half of the company, and was still receiving large dividend payments from it.

Nonetheless, Mr Hunt is now in charge of the whole of the British NHS.  However, his recent public pronouncement that NHS doctors do not work on weekends, and that is why the health service does not provide adequate services on weekends, reveals that he seems not to be very familiar with the organization he is supposed to be leading.  Again, we have seen many examples of leaders of big US health care organizations who seem ill-informed about their organizations, and sometimes hostile to their organization's health care mission.

However, we have not often heard a generic manager simultaneously publicly express so much hostility to health professionals  and so little knowledge about what those professionals actually do.  I suspect that is merely because many US managers are reined in better by their public relations departments and legal counsel. 

We are well into our global experiment involving handing control of virtually everything to managers, administrators, executives, and business people.  I submit it is not going well, and maybe leading us to some ultimate ruination.

As we have said again, again, again... It is way past time for health care professionals to take back health care from generic managers.  True health care reform would restore leadership by people who understand the health care context, uphold health professionals' values, are willing to be held accountable, and put patients' and the public's health ahead of self-interest. 

In the UK, doctors finally seem to be rising in protest against a particularly ill-informed businessman who is currently their boss.  It is past due for US doctors to hold to account similarly ill-informed, and sometimes also mission-hostile generic managers to whom they report.

Saturday, 25 July 2015

Princess Health and Refined Sugar Worsens Blood Lipid Markers of Cardiovascular Disease. Princessiccia

Princess Health and Refined Sugar Worsens Blood Lipid Markers of Cardiovascular Disease. Princessiccia

Blood lipids such as LDL and HDL cholesterol are markers of the biological processes that impact cardiovascular disease, and they are commonly measured to assess cardiovascular risk. When we think about the impact of food on blood lipids, dietary fat typically comes to mind. Yet a new study shows that dietary carbohydrate, specifically high-fructose corn syrup, can have a large impact on blood lipid markers of cardiovascular disease risk.

Introduction

Dietary fats have well-established impacts on blood lipids. For example, in short-term feeding trials, saturated fat tends to increase total cholesterol, increase LDL ("bad") cholesterol, and increase HDL ("good") cholesterol, while the omega-6 polyunsaturated fat linoleic acid decreases total cholesterol and decreases LDL cholesterol. For this reason, dietary advice to reduce cardiovascular risk tends to focus on dietary fat.

The hypothesis that refined dietary sugar is harmful to the cardiovascular system isn't new. In 1972, British physiologist and nutrition researcher John Yudkin published a classic book called Pure, White, and Deadly, which argued, among other things, that refined sugar is harmful to the cardiovascular system. Yet at the time, the supporting data were weak, and the hypothesis was never taken very seriously by the scientific community.

Peter Havel and his group at UC Davis have begun to breathe new life into this hypothesis with their rigorous work on the cardiovascular effects of dietary sugars.
Read more �

Wednesday, 22 July 2015

Princess Health and 2015 Mixed Team Challenge: #SamVsLaura.Princessiccia

The 2015 ENDURrun is just over 2 weeks away!  This year we have 7 teams and 8 ultimates who have entered the event.  So far we have introduced our:

Men's A1 team
Women's A team
Men's Masters team

Today, we are very excited to introduce a challenge between two of our mixed teams.  Bitter rivals Sam (Whiz Kid) and Laura Hewitson will captain their own team as they go head to head in a ruthless (aka fun) week-long competition.  Each team is built to have almost identical finish times for the entire week.  Some stages will include very close match ups, others we expect one team to have an advantage.  If every single person runs to their ability, this could come down to the last few K's in the marathon before the #SamVsLaura champion is crowned!

Without further adieu, here are the rosters along with their current 5K ability according to our rankings page.

Stage 1: Half Marathon

  

Team Sam vs. Team Laura
 Sam Lalonde vs. Lucas Shwed
21:17 vs. ~19:30


 Stage 2: 15K TT

 
Team Sam vs. Team Laura
Cari Rastas- Howard vs. Laura Hewitson
25:53 vs. 26:19

Stage 3: 30K Cross-Country


Team Sam vs. Team Laura
Justin Buis vs. Eric Hunsberger
20:24 vs. 20:22

Stage 4: 10-Mile Hill Run

 
Team Sam vs. Team Laura
Kristin Marks vs. Kimberly Chan
23:47 vs. 23:39

Stage 5: 25.6K Alpine Run


Team Sam vs. Team Laura
Steven Parke vs. Linda Farczadi
18:20 vs. 22:14

Stage 6: 10K TT

 

Team Sam vs. Team Laura
Tracy Urquhart vs. Val Taiakina
21:31 vs. ~20:00

Stage 7: Marathon

 

Team Sam vs. Team Laura
Colin Calvert vs. Nick Burt
18:30 vs. 17:45

During the ENDURrun, make sure to follow the #SamVsLaura hashtag on twitter, along with our stats page tracking the battle HERE.

Sunday, 19 July 2015

Princess Health and Racing: July 18th-19th, 2015.Princessiccia

With less than a month to go until ENDURrun and one week until our SummerTT, the team was once again dispersed all over the place hammering at a diversity of races.  Here's how we did:

Kitchener Downtown Mile

  • Adam Hortian won the inaugural event with a time of 4:37!
  • RunnerRob was right behind him, running 4:45, good for 2nd OA. 
  • Jordan had a very solid race, running 5:06 making him the 3rd H+P-er in the top 5.
  • Nick Burt had an outstanding race, finishing just behind Jordan in 5:06 and placing 6th OA.
  • Coach Dyce came in at 5:15, making him the 5th H+P athlete in the top 8!
  • Justin Buis ran a very solid 5:56 which correlates with his second fastest performance EVER.
  • Robyn Collins ran her first race in months, putting in a very solid effort of 6:09, placing 4th for females.
  • Vicki was in next for the team, running 6:26 and finishing 5th OA for females!
Little Traverse Triathlon
  • Sam Wiebe had an outstanding finish, showing all those American girls how it's done as she won her AG with a time of 1:52!
Gravenhurst Oly Triathon 
  • Lucas Shwed finished with a solid time of 2:21, good for 12th OA and 2nd in his AG.
  • Kimberly Chan completed the course in 2:54, placing her 1st in her AG!
Gravenhurst Give it a Tri
  • Kyle MacKenzie had an outstanding performance, managing a solid 13th OA and 6th place in the high competitive 19&under AG!
Niagara Sprint Triathlon
  • Tracy Urquhart had a very solid performance.  Treating it as a training race, she still managed an outstanding 4th in her AG, 18th OA.
North Face Endurance Challenge
50K
  • Andrew Heij tackled the brutally hot and tough course, finishing 32nd with a time of 6:43:52.
Half Marathon
  • RunnerRob was back in action- running the extremely difficult course in 2:01, placing 3rd OA.
  • Michele Studhalter was in next for the team, finishing with a very respectable 3:01:57.
5K
  • Robyn Collins had an outstanding performance in her second race of the weekend, placing 4th out of females with a time of 42:02. 

Did we miss your result?  Please let us know and we will include you in the next recap!